0567833 - ÚEM 2023 RIV CH eng J - Journal Article
Horák, Josef - Dolníková, Alexandra - Cumaogullari, O. - Čumová, Andrea - Navvabi, Nazila - Vodičková, Ludmila - Levý, M. - Schneiderová, M. - Liška, V. - Anděra, Ladislav - Vodička, Pavel - Opattová, Alena
MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients.
Frontiers in Oncology. Roč. 12, oct (2022), č. článku 959407. ISSN 2234-943X. E-ISSN 2234-943X
R&D Projects: GA ČR(CZ) GA20-03997S; GA ČR(CZ) GA21-27902S; GA ČR(CZ) GX21-04607X
Institutional support: RVO:68378041 ; RVO:86652036
Keywords : miR-140 * colorecal cancer * MRE11 * oxaliplatin * therapy response * DNA damage * DNA repair * miRNA
OECD category: Oncology; Oncology (BTO-N)
Impact factor: 4.7, year: 2022
Method of publishing: Open access
https://www.frontiersin.org/articles/10.3389/fonc.2022.959407/full
Permanent Link: https://hdl.handle.net/11104/0339090
Horák, Josef - Dolníková, Alexandra - Cumaogullari, O. - Čumová, Andrea - Navvabi, Nazila - Vodičková, Ludmila - Levý, M. - Schneiderová, M. - Liška, V. - Anděra, Ladislav - Vodička, Pavel - Opattová, Alena
MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients.
Frontiers in Oncology. Roč. 12, oct (2022), č. článku 959407. ISSN 2234-943X. E-ISSN 2234-943X
R&D Projects: GA ČR(CZ) GA20-03997S; GA ČR(CZ) GA21-27902S; GA ČR(CZ) GX21-04607X
Institutional support: RVO:68378041 ; RVO:86652036
Keywords : miR-140 * colorecal cancer * MRE11 * oxaliplatin * therapy response * DNA damage * DNA repair * miRNA
OECD category: Oncology; Oncology (BTO-N)
Impact factor: 4.7, year: 2022
Method of publishing: Open access
https://www.frontiersin.org/articles/10.3389/fonc.2022.959407/full
Permanent Link: https://hdl.handle.net/11104/0339090